Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pediatrix Medical Group, Inc.MD · Entity 4451 | EVP, Natl & Market Operations | June 01, 2024 | June 04, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pediatrix Medical Group, Inc.
Report date June 01, 2024 · Filed June 04, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 117,281 |
Ending reported balance
After 2024-06-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-06-01 · Grant · Acquired 51,300 · Balance 118,094 F1: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2025, twenty-five percent (25%) of the restricted shares will vest on June 1, 2026 and fifty percent (50%) of the restricted shares will vest on June 1, 2027, subject to the terms of the Plan. Row 2 · 2024-06-01 · Tax withholding · Disposed 813 · Balance 117,281 F2: Represents 813 restricted shares withheld for payment of taxes upon vesting of shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2025, twenty-five percent (25%) of the restricted shares will vest on June 1, 2026 and fifty percent (50%) of the restricted shares will vest on June 1, 2027, subject to the terms of the Plan.
F2: Represents 813 restricted shares withheld for payment of taxes upon vesting of shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2024 Filed Jun 4, 2024 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 813 | $7.31 | $5,943.03 |
DisclosureSEC source: 0000950170-24-068804 · ownership.xml · nonDerivative · entry 2 Wood Lee · CIK 0001965618 · EVP, Natl & Market Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,281 F2 · kind: Represents 813 restricted shares withheld for payment of taxes upon vesting of shares. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 51,300 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-068804 · ownership.xml · nonDerivative · entry 1 Wood Lee · CIK 0001965618 · EVP, Natl & Market Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,094 F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2025, twenty-five percent (25%) of the restricted shares will vest on June 1, 2026 and fifty percent (50%) of the restricted shares will vest on June 1, 2027, subject to the terms of the Plan. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 4,962 | $9.15 | $45,402.30 |
DisclosureSEC source: 0001209191-24-004389 · doc4.xml · nonDerivative · entry 1 Wood Lee · CIK 0001965618 · EVP, Natl & Market Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,794 F1 · kind: Represents 4,962 restricted shares withheld for payment of taxes upon vesting of shares. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 407 | $13.30 | $5,413.10 |
DisclosureSEC source: 0001209191-23-033877 · doc4.xml · nonDerivative · entry 1 Wood Lee · CIK 0001965618 · EVP, Natl & Market Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,756 F1 · kind: Represents 407 restricted shares withheld for payment of taxes upon vesting of shares. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 2,044 | $15.74 | $32,172.56 |
DisclosureSEC source: 0001209191-23-015677 · doc4.xml · nonDerivative · entry 2 Wood Lee · CIK 0001965618 · EVP, Natl & Market Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,163 F2 · kind: Represents 2,044 restricted shares withheld for payment of taxes upon vesting of shares. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 39,806 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-015677 · doc4.xml · nonDerivative · entry 1 Wood Lee · CIK 0001965618 · EVP, Natl & Market Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,207 F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2024, twenty-five percent (25%) of the restricted shares will vest on March 1, 2025 and fifty percent (50%) of the restricted shares will vest on March 1, 2026, subject to the terms of the Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.